Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

Sonja Zweegman; Bronno van der Holt; Ulf-Henrik Mellqvist; Morten Salomo; Gerard  M. J. Bos; Mark-David Levin; Heleen  A. Visser-Wisselaar; Markus Hansson; Annette WG van der Velden; Wendy Deenik; Astrid Gruber; Juleon LLM Coenen; Torben Plesner; Saskia K Klein; Bea Tanis; Damian L. Szatkowski; Rolf Brouwer; Matthijs Westerman; BL Leys; Niels W. C. J. van de Donk; Einar  Haukås; Klaas van der Hem; MF Durian; E (Vera) JM Mattijssen; Harm AM Sinnige; Marian JPL Stevens-Kroef; Pieter Sonneveld; Anders Waage

Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M. J. Bos, Mark-David Levin, Heleen A. Visser-Wisselaar, Markus Hansson, Annette WG van der Velden, Wendy Deenik, Astrid Gruber, Juleon LLM Coenen, Torben Plesner, Saskia K Klein, Bea Tanis, Damian L. Szatkowski, Rolf Brouwer, Matthijs Westerman, BL Leys, Niels W. C. J. van de DonkEinar Haukås, Klaas van der Hem, MF Durian, E (Vera) JM Mattijssen, Harm AM Sinnige, Marian JPL Stevens-Kroef, Pieter Sonneveld, Anders Waage

VU University Medical Center

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	2014
Status	Udgivet - 2014
Begivenhed	56th American Society of Hematology Annual Meeting & Exposition - San Fransisco, CA, USA Varighed: 6. dec. 2014 → 9. dec. 2014 Konferencens nummer: 56

Konference

Konference	56th American Society of Hematology Annual Meeting & Exposition
Nummer	56
Land/Område	USA
By	San Fransisco, CA
Periode	06/12/2014 → 09/12/2014

Dokumenter og links

https://ash.confex.com/ash/2014/webprogram/Paper67729.html

Citationsformater

Zweegman, S., van der Holt, B., Mellqvist, U.-H., Salomo, M., M. J. Bos, G., Levin, M.-D., A. Visser-Wisselaar, H., Hansson, M., WG van der Velden, A., Deenik, W., Gruber, A., LLM Coenen, J., Plesner, T., K Klein, S., Tanis, B., L. Szatkowski, D., Brouwer, R., Westerman, M., Leys, BL., ... Waage, A. (2014). Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG). Abstract fra 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA. https://ash.confex.com/ash/2014/webprogram/Paper67729.html

Zweegman, Sonja ; van der Holt, Bronno ; Mellqvist, Ulf-Henrik et al. / Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG). Abstract fra 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA.

@conference{ccc903c5536349689c34f7b7d1d8b079,

title = "Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)",

author = "Sonja Zweegman and {van der Holt}, Bronno and Ulf-Henrik Mellqvist and Morten Salomo and {M. J. Bos}, Gerard and Mark-David Levin and {A. Visser-Wisselaar}, Heleen and Markus Hansson and {WG van der Velden}, Annette and Wendy Deenik and Astrid Gruber and {LLM Coenen}, Juleon and Torben Plesner and {K Klein}, Saskia and Bea Tanis and {L. Szatkowski}, Damian and Rolf Brouwer and Matthijs Westerman and BL Leys and {W. C. J. van de Donk}, Niels and Einar Hauk{\aa}s and {van der Hem}, Klaas and MF Durian and Mattijssen, {E (Vera) JM} and {AM Sinnige}, Harm and {JPL Stevens-Kroef}, Marian and Pieter Sonneveld and Anders Waage",

year = "2014",

language = "English",

note = "56th American Society of Hematology Annual Meeting & Exposition ; Conference date: 06-12-2014 Through 09-12-2014",

}

Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, M. J. Bos, G, Levin, M-D, A. Visser-Wisselaar, H, Hansson, M, WG van der Velden, A, Deenik, W, Gruber, A, LLM Coenen, J, Plesner, T, K Klein, S, Tanis, B, L. Szatkowski, D, Brouwer, R, Westerman, M, Leys, BL, W. C. J. van de Donk, N, Haukås, E, van der Hem, K, Durian, MF, Mattijssen, EJM, AM Sinnige, H, JPL Stevens-Kroef, M, Sonneveld, P & Waage, A 2014, 'Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)', 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA, 06/12/2014 - 09/12/2014. <https://ash.confex.com/ash/2014/webprogram/Paper67729.html>

Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG). / Zweegman, Sonja; van der Holt, Bronno; Mellqvist, Ulf-Henrik et al.
2014. Abstract fra 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA.

Publikation: Konferencebidrag uden forlag/tidsskrift › Konferenceabstrakt til konference › Forskning › peer review

TY - ABST

T1 - Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)

AU - Zweegman, Sonja

AU - van der Holt, Bronno

AU - Mellqvist, Ulf-Henrik

AU - Salomo, Morten

AU - M. J. Bos, Gerard

AU - Levin, Mark-David

AU - A. Visser-Wisselaar, Heleen

AU - Hansson, Markus

AU - WG van der Velden, Annette

AU - Deenik, Wendy

AU - Gruber, Astrid

AU - LLM Coenen, Juleon

AU - Plesner, Torben

AU - K Klein, Saskia

AU - Tanis, Bea

AU - L. Szatkowski, Damian

AU - Brouwer, Rolf

AU - Westerman, Matthijs

AU - Leys, BL

AU - W. C. J. van de Donk, Niels

AU - Haukås, Einar

AU - van der Hem, Klaas

AU - Durian, MF

AU - Mattijssen, E (Vera) JM

AU - AM Sinnige, Harm

AU - JPL Stevens-Kroef, Marian

AU - Sonneveld, Pieter

AU - Waage, Anders

N1 - Conference code: 56

PY - 2014

Y1 - 2014

M3 - Conference abstract for conference

T2 - 56th American Society of Hematology Annual Meeting & Exposition

Y2 - 6 December 2014 through 9 December 2014

ER -

Zweegman S, van der Holt B, Mellqvist UH, Salomo M, M. J. Bos G, Levin MD et al.. Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG). 2014. Abstract fra 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, USA.